R. D. van Ooijen - Concepedia

Author

R. D. van Ooijen

Utrecht University

Also Known As

R D van Ooijen, R. D. van Ooijen, R.D van Ooijen, R.D. Van Ooijen, R.D. van Ooijen, Ronald D. van Ooijen

Publications

270

Citations

H-Index

Concepts

All Affiliations

Utrecht University Slotervaartziekenhuis The Netherlands Cancer Institute PharmaMar (Spain)

About

R. D. van Ooijen is an author at Utrecht University specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	183
2	Natural Sciences	4	4	80
3	Engineering	3	3	113
4	Anesthesia	1	1	26
5	Applied Physics	1	1	17

R. D. van Ooijen

Publications

246

Citations

H-Index

Page 1

	Year	Citations
Enzymatic Degradation of Cross-Linked Dextrans O. Franssen, R. D. van Ooijen, Douwe de Boer, Macromolecules EngineeringGlycobiologyDextran HydrogelsPolysaccharideEnzymatic Modification	1999	64
Enzymatic Degradation of Methacrylated Dextrans O. Franssen, R. D. van Ooijen, Douwe de Boer, Macromolecules Bioorganic ChemistryEngineeringGlycobiologyPolysaccharideEnzymatic Modification	1997	32
Determination of morphine in serum and cerebrospinal fluid by gas chromatography and selected ion monitoring after reversed-phase column extraction R. H. Drost, R. D. van Ooijen, T. I. Ionescu, Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyMedicineDrug PurityBioanalysisCerebrospinal Fluid	1984	26
Structure elucidation of aplidine metabolites formed <i>in vitro</i> by human liver microsomes using triple quadrupole mass spectrometry Esther Brandon, R. D. van Ooijen, Rolf W. Sparidans, Journal of Mass Spectrometry Biological Mass SpectrometryMetabolomic ProfilingSecondary MetaboliteChemical BiologyMedicinal Chemistry	2005	23
In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug Esther Brandon, Rolf W. Sparidans, R. D. van Ooijen, Investigational New Drugs Vitro CharacterizationHuman Biotransformation PathwaysMedicinePharmacotherapyAnti-cancer Agent	2006	21
Artifact formation due to ethyl thio-incorporation into silylated steroid structures as determined in doping analysis Daan van de Kerkhof, R. D. van Ooijen, Douwe de Boer, Journal of Chromatography A EngineeringSteroid StructuresApplied PhysicsArtifact FormationOrganic Chemistry	2002	17
Determination of N,N′,N″-triethylenethiophosphoramide and its active metabolite N,N′,N″-triethylenephosphoramide in plasma and urine using capillary gas chromatography Rianne J. van Maanen, R. D. van Ooijen, Jan W. Zwikker, Journal of Chromatography B Biomedical Sciences and Applications Capillary Gas ChromatographyPharmaceutical ScienceBiochemistryActive Metabolite NMedicine	1998	15
Structure elucidation and characterization of daunorubicin degradation products Jos H. Beijnen, R.P. Potman, R. D. van Ooijen, International Journal of Pharmaceutics Chemical BiologyBiotransformationBiochemistryNatural SciencesDegradation Reaction	1987	14
Seizure of illicitly produced para-fluorofentanyl: quantitative analysis of the content of capsules and tablets Douwe de Boer, W.-P.J Goemans, V.R Ghezavat, Journal of Pharmaceutical and Biomedical Analysis Drug SafetyPsychoactive DrugQuantitative AnalysisForensic ToxicologyPharmacology	2003	12
Isolation and identification of the C6-hydroxy and C20-hydroxy metabolites and glucuronide conjugate of methylprednisolone by preparative high-performance liquid chromatography from urine of patients receiving high-dose pulse therapy T. B. Vree, C.P.W.G.M. Verwey-van Wissen, A.J. Lagerwerf, Journal of Chromatography B Biomedical Sciences and Applications Pharmaceutical ScienceGlucuronide ConjugatePharmacologyHigh-dose Pulse TherapyPharmacotherapy	1999	11

Page 1